跳至主要内容
临床试验/NL-OMON41268
NL-OMON41268已完成不适用

Early detection of pulmonary exacerbations in mucociliary clearance diseases: Molecular fingerprinting by exhaled breath and microbiome analysis - Early detection of exacerbations in mucociliary clearance diseases

Academisch Medisch Centrum0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
2 至 99(—)

入选标准

  • * CF diagnosis is based on: clinical symptoms in combination with an abnormal sweat test (chloride > 60 mmol/l) and/or identification of mutations in both alleles of the CFTR gene.
  • * PCD diagnosis is based on: a combination of clinical symptoms, abnormal movement of cilia on microscopic evaluation of respiratory epithelial biopsies and epithelial cell cultures, or identification of an ultra structural defect in the cilia by electron microscopy.
  • * * 6 years of age
  • * Stable respiratory disease for at least 6 weeks ( as determined by the treating physician)
  • * Ability to perform lung function measurement

排除标准

  • * Mental retardation
  • * Diabetes Mellitus (CF complication)
  • * Technical unsatisfactory performance of measurements
  • * On the waiting list for lung transplantation
  • * Participation in the PREVEC or VERTEX study (AMC)

研究者

相似试验